Related Experiment Video
Updated: Jan 5, 2026
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
Published on: December 1, 2023
The Potassium Channel Kv1.5 Expression Alters During Experimental Autoimmune Encephalomyelitis
I Bozic1, D Savic1, A Milosevic1
1Department of Neurobiology, Institute for Biological Research "Siniša Stanković"- National Institute of Republic of Serbia, University of Belgrade, Belgrade, Serbia.
Abstract:
Multiple sclerosis (MS) is a chronic, inflammatory, neurodegenerative disease with an autoimmune component. It was suggested that potassium channels, which are involved in crucial biological functions may have a role in different diseases, including MS and its animal model, experimental autoimmune encephalomyelitis (EAE). It was shown that voltage-gated potassium channels Kv1.5 are responsible for fine-tuning in the immune physiology and influence proliferation and differentiation in microglia and astrocytes. Here, we explored the cellular distribution of the Kv1.5 channel, together with its transcript and protein expression in the male rat spinal cord during different stages of EAE. Our results reveal a decrease of Kv1.5 transcript and protein level at the peak of disease, where massive infiltration of myeloid cells occurs, together with reactive astrogliosis and demyelination. Also, we revealed that the presence of this channel is not found in infiltrating macrophages/microglia during EAE. It is interesting to note that Kv1.5 channel is expressed only in resting microglia in the naïve animals. Predominant expression of Kv1.5 channel was found in the astrocytes in all experimental groups, while some vimentin+ cells, resembling macrophages, are devoid of Kv1.5 expression. Our results point to the possible link between Kv1.5 channel and the pathophysiological processes in EAE.
Insights
The Kv1.5 potassium channel, important in immune cell function, decreases in expression during experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis (MS). Its presence is lost in infiltrating immune cells during peak disease.
Area of Science:
- Neuroimmunology
- Channelopathies
- Neuroinflammation
Background:
- Multiple sclerosis (MS) is a chronic neuroinflammatory and neurodegenerative disease with autoimmune characteristics.
- Potassium channels, including Kv1.5, are implicated in immune cell function and potentially in MS pathogenesis.
- Kv1.5 channels influence microglia and astrocyte behavior, key players in neuroinflammation.
Purpose of the Study:
- To investigate the cellular distribution and expression of the Kv1.5 channel in the rat spinal cord during experimental autoimmune encephalomyelitis (EAE).
- To determine the role of Kv1.5 in the immune response and cellular changes occurring during EAE.
Main Methods:
- Quantitative analysis of Kv1.5 transcript and protein expression in rat spinal cord tissue.
- Immunohistochemistry to identify cellular localization of Kv1.5 in different stages of EAE.
- Analysis of Kv1.5 expression in microglia, astrocytes, and infiltrating myeloid cells.
Main Results:
- Kv1.5 transcript and protein levels significantly decreased at the peak of EAE.
- Kv1.5 channels were not detected in infiltrating macrophages/microglia during EAE.
- Kv1.5 was predominantly expressed in astrocytes across all experimental groups and in resting microglia of naive animals.
Conclusions:
- The study suggests a potential link between Kv1.5 channel dysfunction and the pathological processes observed in EAE.
- Reduced Kv1.5 expression during active disease may contribute to neuroinflammation and demyelination in MS.
- Kv1.5 channel expression patterns indicate a specific role in glial cell function during neuroinflammation.
More Related Videos
08:17Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis
Published on: February 23, 2024
10:50Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
Published on: March 26, 2019
